Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 224.30M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -3.75M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 7.00% |
| Sales | 8.4M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 19.00% |
| Dividend | N/A | Price/Book | 46.87 | EPS next 5Y | - | 52W High Chg | -72.00% |
| Recommedations | - | Quick Ratio | 3.63 | Shares Outstanding | 301.86M | 52W Low Chg | 7,400.00% |
| Insider Own | 32.20% | ROA | -26.59% | Shares Float | 254.65M | Beta | 1.25 |
| Inst Own | 35.74% | ROE | -47.43% | Shares Shorted/Prior | -/- | Price | 0.75 |
| Gross Margin | 67.70% | Profit Margin | -44.68% | Avg. Volume | 89,774 | Target Price | - |
| Oper. Margin | 11.71% | Earnings Date | Sep 10 | Volume | 24,174 | Change | 7.14% |
About FUTURA MEDICAL
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
FUTURA MEDICAL News